Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler Shugg

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|December 13, 2019
Progesterone Metabolites Inhibit the Human Ether-a-go-go-Related Gene and Predict QT Interval LengthTyler Shugg, Christian Egly, Chris W Stamatkin, et al.
Genetics|November 28, 2024
Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research ProgramNicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Pharmacogenomics|June 8, 2026
Reduction of next-generation sequencing files for efficient pharmacogenotype extractionHargoon N Kaur, Reynold C Ly, Steven M Bray, et al.
Frontiers in Oncology|February 17, 2022
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case ReportNicholas R Powell, Tyler Shugg, Reynold C Ly, et al.
Pharmacotherapy|February 9, 2026
Cohort Study to Determine the Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant RecipientsYanting Wu, Michael T Eadon, Laurie Schenkelberg, et al.
Clinical Pharmacology and Therapeutics|June 8, 2026
How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022Tyler Shugg, Ashley N Springer, Yemi Gafari, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2024
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohortYanfei Wang, Chenxi Xiong, Weifeng Yu, et al.
Journal of Clinical Pharmacology|April 12, 2023
Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant ProgramEmma Tillman, Miley G Nikirk, Jeanne Chen, et al.
Chronic Diseases and Translational Medicine|June 14, 2024
Analysis of the combined effect of rs699 and rs5051 on angiotensinogen expression and hypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and HypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|December 13, 2019
Progesterone Metabolites Inhibit the Human Ether-a-go-go-Related Gene and Predict QT Interval LengthTyler Shugg, Christian Egly, Chris W Stamatkin, et al.
Genetics|November 28, 2024
Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research ProgramNicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Pharmacogenomics|June 8, 2026
Reduction of next-generation sequencing files for efficient pharmacogenotype extractionHargoon N Kaur, Reynold C Ly, Steven M Bray, et al.
Frontiers in Oncology|February 17, 2022
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case ReportNicholas R Powell, Tyler Shugg, Reynold C Ly, et al.
Pharmacotherapy|February 9, 2026
Cohort Study to Determine the Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant RecipientsYanting Wu, Michael T Eadon, Laurie Schenkelberg, et al.
Clinical Pharmacology and Therapeutics|June 8, 2026
How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022Tyler Shugg, Ashley N Springer, Yemi Gafari, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2024
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohortYanfei Wang, Chenxi Xiong, Weifeng Yu, et al.
Journal of Clinical Pharmacology|April 12, 2023
Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant ProgramEmma Tillman, Miley G Nikirk, Jeanne Chen, et al.
Chronic Diseases and Translational Medicine|June 14, 2024
Analysis of the combined effect of rs699 and rs5051 on angiotensinogen expression and hypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and HypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Pageof 4